SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-221202
Filing Date
2022-08-15
Accepted
2022-08-15 16:11:35
Documents
74
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d320247d6k.htm   iXBRL 6-K 113260
2 EX-99.1 d320247dex991.htm   iXBRL EX-99.1 1091449
3 EX-99.2 d320247dex992.htm EX-99.2 15647
  Complete submission text file 0001193125-22-221202.txt   6708028

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA grcl-20220630.xsd EX-101.SCH 51661
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grcl-20220630_cal.xml EX-101.CAL 49162
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grcl-20220630_def.xml EX-101.DEF 196936
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE grcl-20220630_lab.xml EX-101.LAB 371884
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grcl-20220630_pre.xml EX-101.PRE 323611
68 EXTRACTED XBRL INSTANCE DOCUMENT d320247d6k_htm.xml XML 1353287
Mailing Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030
Business Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030 00862164031522
Gracell Biotechnologies Inc. (Filer) CIK: 0001826492 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39838 | Film No.: 221165746
SIC: 2834 Pharmaceutical Preparations